DKD HELIOS Klinik Wiesbaden GmbH
- Address
- lock Available on a paid plan
Cardiovascular and Kidney Research
At DKD HELIOS Klinik Wiesbaden GmbH, clinical trials in cardiovascular disease and kidney disease focus on conditions such as chronic kidney disease and uncontrolled hypertension. These studies are designed to assess new treatment strategies that may help protect kidney function, reduce heart-related complications, and improve blood pressure control.
- Chronic kidney disease and combined kidney-heart outcome research
- Hypertension studies aimed at better blood pressure management
- Trials evaluating therapies to lower the risk of kidney failure, hospitalization for heart failure, and mortality
This area reflects a strong interest in improving long-term outcomes for patients living with complex cardiorenal conditions.
Neurology and Multiple Sclerosis
A major part of the research portfolio at this site centers on nervous system diseases, especially multiple sclerosis in its relapsing, progressive, and primary progressive forms. The trials are exploring ways to improve symptom control, slow disability progression, and better understand the patient experience of living with these conditions.
- Studies in relapsing multiple sclerosis and progressive multiple sclerosis
- Research on primary progressive multiple sclerosis and treatment effectiveness
- Trials assessing patient-reported impact and continued access to therapy
The site also contributes to research on broader neurological disease management, including efforts to maintain access to ongoing treatment for eligible participants.
Movement Disorders and Symptom Relief
Research in this therapeutic area includes studies on Parkinson's disease and lower limb spasticity, with a focus on easing motor symptoms and improving daily function. These trials are intended to test therapies that may reduce tremor, stiffness, and movement-related impairment.
- Parkinson's disease studies targeting residual tremor
- Trials for lower limb spasticity linked to neurological injury
- Work aimed at improving functional ability and symptom control
This research supports better care for patients whose neurological conditions affect mobility and everyday activities.
Autoimmune and Headache Disorders
The site also participates in studies within immune system diseases, including generalized myasthenia gravis, as well as research on migraine. These trials are evaluating new ways to reduce disease burden, improve symptom relief, and support better day-to-day functioning.
- Generalized myasthenia gravis treatment research
- Migraine studies focused on acute symptom relief
- Trials testing therapies intended to improve quality of life and daily performance
Together, these studies show a broad interest in both chronic autoimmune conditions and common neurological pain disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1F. Hoffmann-La Roche AG2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1F. Hoffmann-La Roche AG6trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in DKD HELIOS Klinik Wiesbaden GmbH
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared with Ocrelizumab in Adult Patients with Primary Progressive Multiple Sclerosis | F. Hoffmann-La Roche AG | Phase III | Not Recruiting | Nov 2020 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ocrelizumab | 5 | Unknown | 2018-05-02 | 2024-12-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.